Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
Miguel D. Ferrer(Health Research Institute of the Balearic Islands), Xavier Capó(Research Institute of Health Sciences), Josep A. Tur(Servei de Salut de les Illes Balears), Carla Busquets-Cortés(Research Institute of Health Sciences), Antoni Pons(Universitat de les Illes Balears), Silvia Tejada(Universitat de les Illes Balears)
Cited by 242
Related Papers
Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial
|International Journal of Epidemiology|2018|325
Effects of total dietary polyphenols on plasma nitric oxide and blood pressure in a high cardiovascular risk cohort. The PREDIMED randomized trial
|Nutrition Metabolism and Cardiovascular Diseases|2014|199
Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial
|Journal of the International Society of Sports Nutrition|2014|150
Acute Administration of Inorganic Nitrate Reduces V˙O2peak in Endurance Athletes
|Medicine & Science in Sports & Exercise|2011|137
Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology
|European Respiratory Journal|2011|124